Surging COVID-19 cases, US-China tensions keep London stocks muted

Trading in London-listed shares was subdued on Friday as rising COVID-19 cases and U.S.-China tensions dented sentiment at the end of a week marked by largely upbeat quarterly earnings and improving economic data.

The blue-chip FTSE 100 was down 0.1% but still on course for its first weekly gain in three as investors bet on more stimulus to drive a post-pandemic economic rebound.

The mid-cap FTSE 250 dipped 0.3%, with losses in industrial, energy and tech-related stocks offsetting gains for consumer goods, healthcare and utility firms.

READ MORE

Oil prices slip on uncertainty over fuel demand, US stimulus

Bank of England expects slower recovery from coronavirus woes

Most airlines expect job cuts over next 12 months: IATA

Stocks in Asia took a hit earlier in the day as Sino-U.S. tensions escalated with U.S. President Donald Trump banning transactions with two popular Chinese apps, Tencent's WeChat and ByteDance's Tiktok.

Hikma Pharmaceuticals Plc jumped 7.4% to the top of the FTSE 100 after raising its annual sales forecast for two of its biggest divisions and reporting higher first-half profit.

But TP ICAP Plc, the world's largest inter-dealer broker, fell 5.4% as it signalled a tepid start to the second half of the year.

Reuters